PHARMA BASE
0441.943.282 · rovalta.com · 26/09/2026
ACTIVE
PHARMA BASE
Financial year 2024 · Closed on 31/12/2024
Net result178,9 k €+327,6 %over 1 year
Revenue75,2 M €+25,1 %over 1 year
Equity2,5 M €+7,6 %over 1 year
Workforce29,0 ETP+26,1 %over 1 year
Overview
Identity
Source · BCE/KBOPHARMA BASE is a Public limited company incorporated in 1990. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Genk. It employs on average 29,0 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0441.943.282
- Incorporation
- 10/10/1990
- Legal form
- Public limited company
- Registered office
- Seinhuisstraat 7 box 1
3600 Genk · FlandreSee on map - Contributed capital
- 1 000 000,00 €
- Latest accounts
- 31/12/2024
- Average workforce
- 29,0 ETP
Activities (NACE)
Joint committees (2)
- 313
- 321
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Financials
Source · NBB, 26 filingsTrend over 13 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 75,2 M € | +25.1% | 60,2 M € | +15.4% | 52,1 M € | -7.2% | 56,2 M € | -1.0% | 56,8 M € |
| EBITDA | 480,1 k € | +37.4% | 349,3 k € | -17.4% | 422,7 k € | -46.4% | 787,9 k € | +30.9% | 601,8 k € |
| Operating result | 364,8 k € | +51.3% | 241,1 k € | -19.9% | 301,2 k € | -53.8% | 651,9 k € | +30.1% | 501,3 k € |
| Net result | 178,9 k € | +328% | 41,8 k € | -71.6% | 147,3 k € | -69.7% | 485,5 k € | +48.4% | 327,2 k € |
| Balance sheet | |||||||||
| Equity | 2,5 M € | +7.6% | 2,3 M € | +1.8% | 2,3 M € | -44.5% | 4,2 M € | +13.2% | 3,7 M € |
| Total assets | 21,1 M € | +10.4% | 19,1 M € | -3.9% | 19,9 M € | +13.3% | 17,5 M € | -4.5% | 18,3 M € |
| Cash | 645,1 k € | -62.6% | 1,7 M € | +39.3% | 1,2 M € | -37.8% | 2 M € | +140% | 828,5 k € |
| Debts | 18,5 M € | +10.8% | 16,7 M € | -4.6% | 17,5 M € | +31.3% | 13,4 M € | -8.9% | 14,7 M € |
| Other | |||||||||
| Workforce | 29,0 ETP | +26.1% | 23,0 ETP | +22.3% | 18,8 ETP | +8.7% | 17,3 ETP | +14.6% | 15,1 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20241 active · 31 ended
Active mandates
Ended mandates
Other companies at this address
Seinhuisstraat 7 3600 GenkFinancials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 23/06/2025 | 31/07/2024 | 11/07/2023 | 22/06/2022 | 24/06/2021 | 16/07/2020 |
| General meeting | 14/06/2025 | 28/06/2024 | 30/06/2023 | 19/05/2022 | 10/06/2021 | 07/07/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 26 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2024 | 14/06/2025 | 23/06/2025 | Dutch | |
| Full model | 31/12/2023 | 28/06/2024 | 31/07/2024 | Dutch | |
| Full model | 31/12/2022 | 30/06/2023 | 11/07/2023 | Dutch | |
| Full model | 31/12/2021 | 19/05/2022 | 22/06/2022 | Dutch | |
| Full model | 31/12/2020 | 10/06/2021 | 24/06/2021 | Dutch | |
| Full model | 31/12/2019 | 07/07/2020 | 16/07/2020 | Dutch | |
| Full model | 31/12/2018 | 26/06/2019 | 11/07/2019 | Dutch | |
| Full model | 31/12/2017 | 29/06/2018 | 19/07/2018 | Dutch | |
| Full model | 31/12/2016 | 05/10/2017 | 09/10/2017 | Dutch | |
| Full model | 31/12/2015 | 30/06/2016 | 04/07/2016 | Dutch | |
| Full model | 31/12/2014 | 31/08/2015 | 14/09/2015 | Dutch | |
| Consolidated accounts | 31/12/2014 | 31/08/2015 | 14/09/2015 | Dutch | |
| Full model | 31/12/2013 | 30/06/2014 | 07/08/2014 | Dutch | |
| Consolidated accounts | 31/12/2013 | 01/01/9999 | 07/08/2014 | Dutch | |
| Full model | 31/12/2012 | 24/10/2013 | 13/12/2013 | Dutch | |
| Consolidated accounts | 31/12/2012 | 25/10/2013 | 18/12/2013 | Dutch | |
| Full model | 31/12/2011 | 26/09/2012 | 27/09/2012 | Dutch | |
| Consolidated accounts | 31/12/2011 | 31/08/2012 | 31/08/2012 | Dutch | |
| Full model | 31/12/2010 | 28/07/2011 | 07/09/2011 | Dutch | |
| Consolidated accounts | 31/12/2010 | 28/07/2011 | 23/12/2011 | Dutch | |
| Full model | 31/12/2009 | 14/07/2010 | 29/10/2010 | Dutch | |
| Consolidated accounts | 31/12/2009 | 20/05/2010 | 21/12/2010 | Dutch | |
| Full model | 31/12/2008 | 30/06/2009 | 10/08/2009 | Dutch | |
| Full model | 31/12/2007 | 03/09/2008 | 06/10/2008 | Dutch | |
| Full model | 31/12/2006 | 31/07/2007 | 31/08/2007 | Dutch | |
| Full modelCorrection | 31/12/2005 | 08/11/2006 | 30/03/2007 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 31 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other12/03/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates21/06/2023ONTSLAGEN - BENOEMINGEN
- Mandates27/07/2020ONTSLAGEN - BENOEMINGEN
- Mandates18/11/2019ONTSLAGEN - BENOEMINGEN
- Mandates17/12/2018DEMISSIONS, NOMINATIONS
- Mandates01/08/2018ONTSLAGEN - BENOEMINGEN
- Mandates11/04/2018ONTSLAGEN - BENOEMINGEN
- Mandates26/01/2018ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024178,9 k €↑
- 2023Annual accounts 202341,8 k €↓
- 2022Annual accounts 2022147,3 k €↓
- 2021Annual accounts 2021485,5 k €↑
- 2020Annual accounts 2020327,2 k €↓
- 2019Annual accounts 2019674 k €↓
- 2018Annual accounts 2018935,5 k €↑
- 2017Annual accounts 2017275,4 k €↓
- 2017Name changePharma Base
- 2010Annual accounts 2010728,4 k €↑
- 2009Annual accounts 200920,8 k €↑
- 2008Annual accounts 2008-6,9 k €↑
- 2007Annual accounts 2007-102 k €↓
- 2007Name changePATRONA PHARMA
- 2006Annual accounts 2006-61,9 k €
- 2006Name changePATRONA PHARMA GROUP INTERNATIONAL
- 10/10/1990IncorporationPublic limited company